Intussell

Intussell is a South Korean biotechnology company specializing in the development of advanced drug delivery systems, specifically focusing on tapered-end microneedle technology. The company's proprietary platform aims to overcome the limitations of traditional needle injections and first-generation microneedles by ensuring efficient skin penetration and precise drug delivery with minimal pain. Intussell targets a wide range of applications, including the delivery of vaccines, insulin for diabetes management, and active ingredients for medical aesthetics. By leveraging its unique manufacturing process, the company seeks to provide a more patient-friendly and effective alternative for transdermal administration of both small and large molecule therapeutics.